VOYA Investment Management
EGRX

VOYA Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

VOYA Investment Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,774
Closed -$236K – 2918
2022
Q1 		$236K Buy
4,774
+297
+7% +$14.3K ﹤0.01% 2288
2021
Q4 		$228K Buy
4,477
+192
+4% +$9.95K ﹤0.01% 2433
2021
Q3 		$239K Buy
+4,285
New +$211K ﹤0.01% 2475
2021
Q2 		– Sell
-8,139
Closed -$340K – 2917
2021
Q1 		$340K Buy
8,139
+868
+12% +$40.3K ﹤0.01% 2256
2020
Q4 		$339K Buy
7,271
+44
+0.6% +$2.06K ﹤0.01% 2133
2020
Q3 		$307K Sell
7,227
-71
-1% -$3.11K ﹤0.01% 1938
2020
Q2 		$350K Sell
7,298
-968
-12% -$48.3K ﹤0.01% 1883
2020
Q1 		$380K Sell
8,266
-5,171
-38% -$259K ﹤0.01% 1793
2019
Q4 		$807K Buy
13,437
+135
+1% +$8.05K ﹤0.01% 1586
2019
Q3 		$752K Buy
13,302
+4,477
+51% +$252K ﹤0.01% 1501
2019
Q2 		$491K Buy
8,825
+4,547
+106% +$237K ﹤0.01% 1791
2019
Q1 		$216K Buy
+4,278
New +$190K ﹤0.01% 2234
2018
Q4 		– Sell
-4,030
Closed -$279K – 2589
2018
Q3 		$279K Hold
4,030
– – ﹤0.01% 2180
2018
Q2 		$305K Buy
+4,030
New +$254K ﹤0.01% 2130
2017
Q4 		– Sell
-4,204
Closed -$251K – 2607
2017
Q3 		$251K Hold
4,204
– – ﹤0.01% 2263
2017
Q2 		$332K Buy
4,204
+675
+19% +$55.2K ﹤0.01% 2089
2017
Q1 		$293K Hold
3,529
– – ﹤0.01% 2064
2016
Q4 		$280K Sell
3,529
-593
-14% -$43.1K ﹤0.01% 2099
2016
Q3 		$289 Buy
+4,122
New +$228K ﹤0.01% 2061
2016
Q1 		– Sell
-3,568
Closed -$316K – 2532
2015
Q4 		$316K Hold
3,568
– – ﹤0.01% 2028
2015
Q3 		$264K Sell
3,568
-603
-14% -$50.2K ﹤0.01% 2113
2015
Q2 		$337K Buy
+4,171
New +$272K ﹤0.01% 2183

Other funds holding EGRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VOYA Investment Management's EGRX Position: Q2 2022 in Review

VOYA Investment Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2022, closing a stake of 4,774 shares — an estimated $236K sold.

VOYA Investment Management first reported a position in EGRX in Q2 2015 and held it in 22 quarters. The position peaked at $807K in Q4 2019. 163 funds tracked by Wall St. Rank hold EGRX as of Q2 2022.

  • VOYA Investment Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 4,774 Eagle Pharmaceuticals, Inc. shares in Q2 2022, an estimated $236K.
  • VOYA Investment Management first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 22 quarters.
  • VOYA Investment Management's Eagle Pharmaceuticals, Inc. position peaked at $807K in Q4 2019.
  • 163 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.